Pharmacokinetics of Single-Dose Oral Ciprofloxacin in Patients Undergoing Chronic Ambulatory Peritoneal Dialysis
|
|
- Edmund Doyle
- 5 years ago
- Views:
Transcription
1 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 1986, p /86/ $02.00/0 Copyright 1986, Americn Society for Microbiology Vol. 30, No. 1 Phrmcokinetics of Single-Dose Orl Ciprofloxcin in Ptients Undergoing Chronic Ambultory Peritonel Dilysis ITAMAR SHALIT,' ROBERT B. GREENWOOD,2 MELVIN I. MARKS,'* JAMES A. PEDERSON,3 AND DONALD L. FREDERICK4 Deprtment of Peditrics, Division of Infectious Diseses,' nd Deprtments of Phrmceutics,2 Medicine,3 nd Pthology,4 University of Oklhom Helth Sciences Center, Oklhom City, Oklhom Received 12 December 1985/Accepted 30 April 1986 The prevention nd tretment of peritonitis in ptients undergoing peritonel dilysis is often complicted by severl fctors, including nephrotoxicity, requirement for hospitliztion, prenterl ntibiotic therpy, nd infection cused by resistnt microorgnisms. Ciprofloxcin, new crboxyquinolone derivtive, my offer the dvntges of orl dministrtion, brod spectrum of ntibcteril ctivity, nd sfety for the mngement of these ptients. The phrmcokinetics of ciprofloxcin in serum nd peritonel fluid of eight dult ptients undergoing chronic mbultory peritonel dilysis (CAPD) were investigted. Ech ptient ingested single 750-mg dose of ciprofloxcin, nd drug concentrtions were mesured by high-pressure liquid chromtogrphy in serum nd peritonel fluid for 48 h fter the dose. Serum concentrtions reched men pek of 3.6,ug/ml 1 to 2 h fter the orl dose. The men terminl serum hlf-life ws 16.8 h, nd the men peritonel fluid/serum concentrtion rtio ws The men pek ciprofloxcin concentrtion in peritonel fluid ws 1.3,ug/ml, nd the bioctivity of the drug in peritonel fluid ws confirmed. These dt indicted tht therpeutic concentrtions of ciprofloxcin ginst bcteril pthogens commonly ssocited with peritonitis in CAPD ptients my be chievble in the peritonel fluid fter orl dministrtion to ptients undergoing CAPD. In ddition, the phrmcokinetic dt provide guidelines for further clinicl studies of orl ciprofloxcin in CAPD ptients. Chronic mbultory peritonel dilysis (CAPD) is commonly used for the tretment of end-stge renl filure. Peritonitis is the mjor compliction ssocited with CAPD, the most common custive bcteri being grm-positive cocci (Stphylococcus epidermidis, Stphylococcus ureus, nd Streptococcus spp.) nd grm-negtive rods (members of the fmily Enterobctericee nd Pseudomons eruginos) (3). Ciprofloxcin (1-cyclopropyl-6-fluoro-1,4-dehydro-4-oxo-7-[1-piperzinyl]-3-quinolinecrboxylic cid hydrochloride), new crboxyquinoline derivtive, is highly effective in vitro ginst these orgnisms. Moreover, ciprofloxcin ws found to hve bctericidl ctivity in vitro ginst P. eruginos in peritonel fluid obtined from ptients undergoing CAPD (6). Thus, ciprofloxcin my prove to be useful therpeutic gent in CAPD-relted peritonitis, provided tht dequte concentrtions re chievble in peritonel fluid. The phrmcokinetics of ciprofloxcin hve been studied previously fter single nd multiple doses in helthy volunteers nd fter single orl dose in ptients with renl dysfunction, including ptients undergoing hemodilysis (1). In the bove studies, ciprofloxcin ws found to be sfe nd well tolerted. Since phrmcokinetics of quinolones in ptients on CAPD hve not been reported, we determined these prmeters in the serum nd peritonel fluid fter single orl dose of ciprofloxcin in uninfected ptients undergoing CAPD. MATERIALS AND METHODS Eight mle subjects between the ges of 38 nd 74 yers (men, 56.8 yers) were enrolled in the study. Approvl for the study ws obtined from the Institutionl Review Bord * Corresponding uthor. of the Oklhom Teching Hospitls, nd informed consent ws obtined from ech subject before enrollment. Enrollment criteri included the following: ge, over 18 yers; dignosis of chronic, end-stge renl filure treted by CAPD for more thn 1 month; no ntibiotic therpy during the 14-dy period before the study; nd no evidence of peritonitis during the sme time period, s evidenced by clinicl signs nd peritonel fluid cell count nd cultures. Before enrollment, detiled medicl history ws obtined nd complete physicl exmintion ws performed on ech subject, long with complete blood count nd differentil, cogultion studies, chemistry profiles (including blood glucose, blood ure nitrogen, cretinine, electrolytes, clcium, phosphorus, lkline phosphtse, serum glutmic pyruvic trnsminse, lctte dehydrogense, gmm-glutmyltrnsferse, bilirubin, totl protein, nd lbumin), urinlysis (in ptients who produced urine), nd peritonel fluid cell count nd cultures. Except for bnormlities ssocited with their end-stge renl disese, subjects demonstrted no other biochemicl bnormlities nd were judged to be in stble clinicl condition. Physicl exmintion nd the bove-mentioned lbortory tests were repeted 24 nd 48 h fter drug dministrtion to ssess sfety nd monitor potentil side effects. On the dy of the study, fter n overnight fst, n indwelling intrvenous ctheter with heprin lock ws plced in forerm vein of ech subject for repeted blood smpling. To enble frequent peritonel fluid smpling, three-wy stopcock connector ws plced, under sterile conditions, between the dilysis bg extension tubing nd the peritonel dilysis ctheter. Smples were obtined through sterilely plced rubber-cp extension dptor (PRN Adptor) ttched to the three-wy connector. The rubber cp ws clensed with povidone-iodine solution before smpling. Between smplings, the entire connector 152
2 VOL. 30, 1986 PHARMACOKINETICS OF CIPROFLOXACIN IN CAPD PATIENTS 153 TABLE 1. Concomitnt medictions received by ech ptient Presence (+) or bsence (-) of the following mediction: Ptient Vitmin Stool Phosphte Others supplement softener binders Digoxin ZnSO4 FeSO4 CCO2 A Clonidine B Allopurinol C Diphenhydrmine D Trnsderml nitroglycerin E Synthroid F G Trnsderml nitroglycerin, proprnolol H _ site ws plced between two lyers of povidone-iodine- mtogrphy (HPLC) (7). Smple processing ws done in the soked guzes. following wy. Serum smples were filtered through 0.45-,um After bse-line peritonel fluid nd blood smples were membrne filters (Nihon Millipore, Kgyo, Jpn). These obtined, ech subject received single 750-mg cplet of filters re designed for smll smple volumes nd prevent ciprofloxcin (By , Miles Phrmceuticls, West H- clogging of the HPLC columns by smll fibrin prticles. ven, Conn.) with 200 ml of tp wter. The subjects remined Some ser were diluted 1:1 with mobile phse. Urine smfsting until 1 to 2 h fter dosing, when they were llowed to ples were diluted with mobile phse until the vlues were ingest their usul brekfst nd their medictions tken between 0.5 nd 12,ug/ml, which ws the liner rnge. The regulrly for underlying conditions (Tble 1). Blood smples peritonel fluids were used directly without processing. The for drug ssy were obtined predose nd 0.25, 0.5, 1, 1.5, 2, HPLC ws performed by using 1084 HPLC device (Hew- 2.5, 3, 4, 6, 8, nd 10 h fter the dose. The venous ctheter lett-pckrd Co., Plo Alto, Clif.) with fluorescence ws removed fter the 10-h smple. Additionl smples were detector (McPherson model FL-749). The detector ws obtined by venipuncture t 24 nd 48 h fter the dose. All operted with n excittion wvelength of 278 nm nd n blood smples were centrifuged, nd the serum ws sep- emission wvelength of 447 nm. The flow rte ws 1.80 rted, smpled, nd stored t -70 C until drug ssy ws ml/min, nd the oven temperture ws 45 C. A Brownlee performed. C-18 (5,um) column nd precolumn were used. The mobile The peritonel dilysis schedule in ech ptient included phse ws composed of 1.45 ml of ortho-phosphoric cid two consecutive 6-h cycles followed by 3- to 4-h cycle nd dded to pproximtely 500 ml of distilled wter nd titrted n 8-h overnight cycle. The dilysis fluid used ws Dinel to ph of 3.0 with tetrbutylmmonium hydroxide (40% by (Trvenol Lbortories, Morton Grove, Ill.) contining 1.5% weight solution; Aldrich Chemicl Co., Milwukee, Wis.), glucose for the first three cycles nd 4.25% glucose for the followed by dilution to 1,000 ml with deionized wter. overnight cycle. The study drug ws dministered in ech Methnol, t finl concentrtion of 5% (HPLC grde), ws cse immeditely upon strting the first 6-h cycle in the used s the orgnic modifier for ll nlyses. Stndrds were morning. Peritonel fluid smples were collected predose mde from ciprofloxcin powder dded to the mobile phse. nd 0.5, 1, 2, 3, 4, 6, 6.5, 7, 8, 8.5, 9, 10, 12, 16, 24, 30, 36, Stndrds were lso mde in ech of the fluids nlyzed, but 40, nd 48 h fter drug dministrtion. The smples collected there ws no observed difference in the pek heights befter 12 h were obtined from the drined peritonel fluid t tween the queous nd fluid-bsed stndrds. Quntittion the end of ech dilysis cycle. Smples were stored t -70 C ws bsed on pek heights. The within-run coefficients of until drug ssy. vrition t levels between 0.4 nd 12.0,ug/ml were 2 to Drug ssy in ech of the fluids tested (serum, peritonel 3.5%. The limit of detection ws 20 nglml, with within-run fluid, nd urine) ws done by high-performnce liquid chro- precision (coefficient of vrition) of 20%. TABLE 2. Concentrtion of ciprofloxcin in serum of CAPD ptients fter single 750-mg orl dose Ciprofloxcin concn (1Lg/ml) in ptient: Time (h) Men concn + SD H B C D F G E A 0 ND ND ND ND ND ND ND ND ND ND ND ± ± ± ± ± ± ± ± ± ± ND ND 0.60 ND 0.30 ND 0.20 ND, Not detectble (s0.20,ug/ml).
3 154 SHALIT ET AL. ANTIMICROB. AGENTS CHEMOTHER. TABLE 3. Ciprofloxcin concentrtion in dilysis fluid during first exchnge in eight CAPD ptients fter single 750-mg dose Ciprofloxcin concn (,ug/ml) in ptient: Time (h) C F D B G H E Men concn ± SD (rnge) C F D B G H E A 0 ND ND ND ND ND ND ND ND ND 0.5 ND ND ND ND 0.27 ND ND ND ND ND ND ND 0.37 ± 0.35 (0-1.0) ± 0.64 ( ) ± 0.67 ( ) ± 0.67 ( ) ± 0.63 ( ) ± 0.60 ( ) ND, Not detectble (<0.20,uglml). After initil phrmcokinetic dt indicted tht pek ciprofloxcin concentrtions in peritonel fluid were ttined 6 h fter drug dministrtion, the 6-h peritonel smples of six ptients were evluted for their bctericidl ctivity ginst the most common microorgnisms ssocited with CAPD-relted peritonitis (in two dditionl ptients, the mount of peritonel fluid smples were insufficient). The microorgnisms tested were S. epidermidis ATCC 12228, S. ureus ATCC 29213, Escherichi coli ATCC 28522, nd P. eruginos ATCC The bctericidl ctivity of the peritonel fluid smples ws tested by seril twofold dilution in Mueller-Hinton broth (1:2 to 1:128 dilutions), inoculted with 5 x 105 CFU of the microorgnisms per ml. After 18 h of incubtion, the tubes were ssessed for gross turbidity. Peritonel fluid inhibitory power ws defined s the highest dilution showing no turbidity; to ssess bctericidl ctivity, 10 R1 ws trnsferred from ech tube onto blood gr. Pltes were red fter 18 h of incubtion, nd the bctericidl ctivity ws defined s the highest dilution showing c5 colonies on subplting (.99.9% killing). Phrmcokinetic dt nlysis. Concentrtions of ciprofloxcin obtined in serum nd peritonel dilysis fluid versus time were plotted semilogrithmiclly. The hlf-life of the slowest phse nd the corresponding rte constnt (1) 0 4 -J TME IN HOURS FIG. 1. Men ciprofloxcin concentrtion in serum nd dilysis fluid fter single orl dose (750 mg). Bgs were exchnged t 6, 12, 16, 24, 30, 36, 40, nd 48 h.!, Serum; *, dilysis fluid. were clculted from visully determined best-fit lines drwn to the terminl log-liner segment of the curve. Mximum concentrtion in plsm nd time to mximum plsm concentrtion were lso obtined grphiclly, while re under the curve from 0 h to infinity (AUCO) ws clculted by the trpezoidl rule, with AUC48 estimted by dividing the 48-h plsm concentrtion by P. Rtios of peritonel dilysis concentrtions to serum concentrtions were clculted to determine pproch to equilibrium during the 4-, 6-, or 8-h-cycle exchnge lengths. Vlues of systemic clernce divided by frction of dose bsorbed (F) were obtined by dividing the dose by the AUC from 0 to oo. Volumes of distribution (Vp) divided by F were obtined by dividing the rtio of systemic clernce nd F vlues by the rte constnt,,b. RESULTS All eight subjects completed the study s scheduled. The procedures enbling multiple blood nd peritonel fluid smplings were well tolerted nd cused no complictions. The subjects did not experience ny side effects fter the single ciprofloxcin dose. Physicl exmintion nd lbortory tests performed 24 nd 48 h fter drug dministrtion disclosed no significnt chnges from bse-line dt obtined before drug dministrtion. Concentrtions of ciprofloxcin in serum for the entire 48-h period re shown in Tble 2, nd the concentrtions in peritonel fluid for the first dilysis cycle re shown in Tble 3. Plots of these vlues re shown in Fig. 1. Serum concentrtions rose rpidly, with peks in 1 to 2 h, nd declined slowly with cler multiexponentil chrcter. During ech dilysis exchnge, the concentrtions rose rpidly in the first severl hours, then more slowly pproched equilibrium. The functionl bioctivity of ciprofloxcin in the peritonel fluid of six ptients ws tested ginst four representtive bcteril pthogens. The results generlly demonstrted bctericidl ctivity tht correlted well with the peritonel fluid concentrtion of ciprofloxcin nd the MBC of the bcteri (Tble 4). For ny prticulr ptient, the 4-h exchnges usully produced lower rtios of peritonel fluid concentrtions thn the 6-h exchnges, indicting tht equilibrium hd not been reched (Tble 5). The 8-h overnight exchnges were conducted by using 4.25% glucose solutions, which yielded returned volumes significntly lrger thn those from the 1.5% glucose solutions; this resulted in rtios of peritonel fluid/serum concentrtion lower thn the 6-h exchnge rtios in severl cses. Mximum peritonel fluid/serum rtios occurred t the end of the dilysis exchnge for ll ptients during the first exchnge. Therefter, mximum rtios oc-
4 VOL. 30, 1986 PHARMACOKINETICS OF CIPROFLOXACIN IN CAPD PATIENTS 155 TABLE 4. Bctericidl ctivity of peritonel fluid obtined 6 h fter single 750-mg orl ciprofloxcin dose in ptients undergoing CAPD Bctericidl ctivity of ciprofloxcin ginst: Ciprofloxcin concn Ptient E. coli ATCC S. ureus P. eruginos S. epidermidis in fluid (HPLC) (MBC, ATCC ATCC ATCC (,ug/ml) -0.06) (MBC, 0.25) (MBC, 0.5) (MBC, 0.25) E 1:64 1:4 1:2 1: G 1:64 1:4 1:2 1: II 1:128 1:8 1:4 1: B 1:64 1:4 1:4 1: D 1:128 1:4 1:2 1: A 1:64 1:2 <1:2 1: Expressed s highest dilution demonstrting -99.9% bcteril killing. curred t or before the end of the cycle; this ws due to periods of disequilibrium between the decresing serum concentrtion nd the dilysis fluid in the peritonel cvity. For ll dilysis exchnges conducted, the overll men dilysis fluid/serum concentrtion rtio ws 0.64; in other words, peritonel drug concentrtions pproched 64%, on the verge, during the dilysis cycle. The verge pek concentrtion of ciprofloxcin in peritonel fluid ws 1.32 jig/ml nd occurred during the first dilysis exchnge. The AUC nd terminl hlf-life dt nd other phrmcokinetic prmeters re presented in Tble 6. DISCUSSION Ciprofloxcin ws rpidly bsorbed with men pek serum concentrtions between 1 nd 2 h of 3.61 j,g/ml. This is similr to the dt reported for norml volunteers by Gonzlez et l. (4), who obtined peks of 3.41 to 4.21,ug/ml 1 to 1.5 h fter 750-mg dose. The men terminl serum hlf-life of 16.8 h (rnge, 10.7 to 25.2) in our ptients with end-stge renl disese ptients is not unexpected nd differs drmticlly from the 3.9 to 6.6 h reported for norml subjects (2, 8). Men vlues of systemic clernce divided by F of ml/min nd V,IF of 489 liters from our study must be interpreted crefully, since neither prmeter cn be clculted independently of the biovilbility fctor. Assuming n F of 0.75, which is similr to the vlues of 0.63 to 0.77 found by Hoffken et l. (5), men Vp of 367 liters nd systemic clernce of 280 ml/min re obtined. The lrge Vp vlue indictes extensive tissue distribution of the drug; this vlue is similr to tht reported by Hoffklen et l. for ptients with norml renl function who were dministered 750-mg dose. However, the systemic clernce estimte of 280 ml/min is considerbly lower thn the vlues of ml/min in ptients with norml renl function reported by Wise et l. (8). Becuse our ptients hd compromised clernce mechnisms, this finding ws not unexpected. Since the volume of distribution ws reltively unffected, the vlue of,b ws lower thn norml. It should be pointed out tht the frction of the dose removed vi the peritonel fluid pthwy ws miniml, from 0.4 to 1.6%; likewise, in the few ptients who produced ny urine, the gretest mount eliminted by ny ptient ws only 1% of the dose. Therefore, the kinetic prmeter estimtes would be expected to be reltively unffected by removl of the drug by either of these routes in this popultion. Ciprofloxcin concentrtions in the peritonel fluid pproched 64% of the serum vlues when the exchnge cycles of 4, 6, nd 8 h were used in this study. Concentrtions rose rpidly in the first 1 to 2 h fter ech exchnge. Bctericidl ctivity of the peritonel fluid obtined t the end of the first exchnge showed gretest ctivity ginst E. coli, nd lesser ctivity ginst Stphylococcus nd Pseudomons spp., reflecting the greter in vitro susceptibility of members of the fmily Enterobctericee to ciprofloxcin (Tble 6). The method of superposition ws used with men serum dt to predict eventul stedy-stte levels t dose of 750 mg every 12 h. This yielded predictions of serum concentrtions of 2.4 nd 5.5,ug/ml immeditely before nd t 2 h fter the dose ws given t stedy stte. These vlues re higher thn those of Gonzlez et l. (4), but tht study used helthy volunteers; the longer hlf-life in CAPD ptients would result in greter ccumultion of the drug. Pek levels in dilysis fluid would be predicted to be bout 64% (3.3,ug/ml) of the serum concentrtion of 5.5,ug/ml. It is nticipted tht this peritonel concentrtion of ciprofloxcin would be effective ginst mny orgnisms responsible for peritonel infections in CAPD ptients. Since our dt were derived from CAPD ptients without peritonel inflmmtion, dditionl studies should be conducted in ptients with peritonitis to ssess the permebility of ciprofloxcin through in- TABLE 5. Highest rtio of peritonel fluid concentrtion of ciprofloxcin to serum concentrtions during ech dilysis exchnge nd mximum peritonel fluid concentrtion obtined during ny exchnge Rtio t time (h) (At): Mximum peritonel 6 (6) 12 (6) 16 (4) 24 (8) 30 (6) 36 (6) 40 (4) 48 (8) fluid concn (jjg/rl) Ptient flu pgrl) A B C D E F G H
5 156 SHALIT ET AL. ANTIMICROB. AGENTS CHEMOTHER. TABLE 6. Selected phrmcokinetic prmeters of single 750-mg orl dose of ciprofloxcin in eight CAPD ptients Prmeter Ptient (wt [kg]) (/CPmx t (h)b 1 (h-1) (h) AUCo0 CL/F VWIF t4/21 (j.g/rnl) "' (p.g h/mi) (mi/min) (liters) A (89) B (81) C (88) D (97.5) E (92) F (79.3) c G (72) H (75) Men SD Rnge Cp.,g Mximum plsm concentrtion; t,,, time to mximum plsm concentrtion; t:/20, elimintion hlf-life; CL, systemic clernce. b Estimted grphiclly. C 48-h smple missing. flmed peritonel membrnes. It is difficult to predict the effect of peritonel inflmmtion on ciprofloxcin concentrtions in the peritonel cvity. On one hnd, inflmmtion with ssocited hyperemi my increse locl drug concentrtion nd increse permebility in mnner similr to conditions such s meningel Qr synovil inflmmtion; on the other hnd, the function of the peritonel membrne s dilysis membrne is usully hmpered by inflmmtion nd the overll drug clernce my be reduced. Nevertheless, the phrmcokinetis fetures demonstrted in our study, s well s the orl route of dministrtion nd brod spectrum of ntimicrobil ctivity, support potentil role for ciprofloxcin in the mngement of peritonitis nd provide guidelines for further clinicl studies of orl ciprofloxcin in CAPD ptients. LITERATURE CITED 1. Boelert, J., Y. Vlcke, M. Schurgers, R. Dneels, M. Rosseneu, M. T. Rosseel, nd M. G. Bogert The phrmcokinetics of ciprofloxcin in ptients with impired renl function. J. Antimicrob. Chemother. 16: Brumfitt, W., I. Frnklin, D. Grdy, J. M. T. Hmilton-Miller, nd A. Iliffe Chnges in the phrmcokinetics of ciprofloxcin nd fecl flor during dministrtion of 7-dy course to humn volunteers. Antimicrob. Agents Chemother. 26: Gokl, R., D. M. A. Frncis, T. H. J. Goodship, A. J. Bint, J. M. Rmos, R. E. Ferner, G. Proud, M. K. Wrd, nd D. N. S. Kerr Peritonitis in continuous mbultory peritonel dilysis. Lncet ui: Gonzlez, M. A., F. Uribe, S. D. Moisen, A. P. Fuster, A. Selen, P. G. Welling, nd B. Pinter Multiple-dose phrmcokinetics nd sfety of ciprofloxcin in norml volunteers. Antimicrob. Agents Chemother. 26: H6ffken, G., H. Lode, C. Prinzing, K. Borner, nd P. Koeppe Phrmcokinetics of ciprofloxcin fter orl nd prenterl dministrtion. Antimicrob. Agents Chemother. 27: Shlit, I., D. IF. Welch, V. H. Sn Joquin, nd M. I. Mrks In vitro ntibcteril ctivities of ntibiotics ginst Pseudomons eruginos in peritonel dilysis fluid. Antimicrob. Agents Chemother. 27: Weber, A., D. Chffin, A. Smith, nd K. E. Opheim Quntittion of ciprofloxcin in body fluids by high-pressure liquid chromtogrphy. Antimicrob. Agents Chemother. 27: Wise, R., R. M. Lockley, M. Webberly, nd J. Dent Phrmcokinetics of intrvenously dministered ciprofloxcin. Antimicrob. Agents Chemother. 26:
Clinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number
EudrCT Number 2012-001531-31 A Phse I, Rndomised, Open-lbel, 3-wy Cross-over Study in Helthy Volunteers to Demonstrte the Bioequivlence of the Nloxegol 25 mg Commercil nd Phse III Formultions nd to Assess
More informationComparison of three simple methods for the
J. clin. Pth. (1967), 2, 5 Comprison of three simple methods for the ssessment of 'free' thyroid hormone T. M. D. GIMLETTE1 From the Rdio-Isotope Lbortory, St. Thoms's Hospitl, London SYNOPSIS A dilysis
More informationEVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1
Swine Dy 2001 Contents EVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1 C. W. Hstd, S. S. Dritz 2, J. L. Nelssen, M. D. Tokch, nd R. D. Goodbnd Summry Two trils were
More informationAntiviral Therapy 2015; 20: (doi: /IMP2920)
Antivirl Therpy 2015; 20:397 405 (doi: 10.3851/IMP2920) Originl rticle Sfety, tolerbility nd phrmcokinetics of dorvirine, novel HIV non-nucleoside reverse trnscriptse inhibitor, fter single nd multiple
More informationphosphatase isoenzyme activity: estimation of
J Clin Pthol 1988;41:202-206 Quntittive method for determining serum lkline phosphtse isoenzyme ctivity: estimtion of intestinl component M J PEAKE, M PEJAKOVIC, G H WHITE From the Deprtment ofbiochemistry
More informationEFFECTS OF INGREDIENT AND WHOLE DIET IRRADIATION ON NURSERY PIG PERFORMANCE
Swine Dy 21 EFFECTS OF INGREDIENT AND WHOLE DIET IRRADIATION ON NURSERY PIG PERFORMANCE J. M. DeRouchey, M. D. Tokch, J. L. Nelssen, R. D. Goodbnd, S. S. Dritz 1, J. C. Woodworth, M. J. Webster, B. W.
More informationDose-dependent effect of daptomycin on the artificial prolongation of prothrombin time in coagulation abnormalities: in vitro verification
Hshimoto et l. BMC Phrmcology nd Toxicology (2017) 18:74 DOI 10.1186/s40360-017-0180-3 RESEARCH ARTICLE Open Access Dose-dependent effect of dptomycin on the rtificil prolongtion of prothrombin time in
More informationPharmacokinetics of a New Quinolone, AM-833, in Mice, Rats, Rabbits, Dogs, and Monkeys
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 19, p. 30-309 00-0//0030-0$0.00/0 Copyright 19, Americn Society for Microbiology Vol. 30, No. Phrmcokinetics of New Quinolone, AM-33, in Mice, Rts, Rbbits, Dogs,
More informationGentamicin, Tobramycin, Netilmicin, or Amikacin and Carbenicillin or Ticarcillin
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1979, p. 592-596 66-484/79/4-592/5$2./ Vol. 15, No. 4 Effect of Time nd Concentrtion Upon Interction Between Gentmicin, Tobrmycin, Netilmicin, or Amikcin nd
More informationof comorbid conditions, interventions Diagnosis and treatment, treatment reduction of risk factors for CVD to slow disease progression,
Tble 5.1. NKF Clssifiction of Chronic Kidney Disese nd Clinicl Fetures Stge Description GFR (ml/ min/1.73 m 2 ) U.S. Prevlence, b # Affected (%) Clinicl Fetures Action Pln c At incresed risk for CKD >60
More informationfunction. As a result of a recent increase in the dose being used in clinical investigations, this study was undertaken to evaluate
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jn. 1992, p. 115-12 66-484/92/1115-6$2./ Copyright C 1992, Americn Society for Microbiology Vol. 36, No. 1 Phrmcokinetics of Teicoplnin upon Multiple-Dose Intrvenous
More informationSingle-Dose Accumulation Pharmacokinetics of Tobramycin and Netilmicin in Normal Volunteers
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1987, p. 65-69 66-484/87/465-5$2./ Copyright 1987, Americn Society for Microbiology Vol. 31, No. 4 Single-Dose Accumultion Phrmcokinetics of Tobrmycin nd Netilmicin
More informationEFFECTS OF AN ACUTE ENTERIC DISEASE CHALLENGE ON IGF-1 AND IGFBP-3 GENE EXPRESSION IN PORCINE SKELETAL MUSCLE
Swine Dy 22 Contents EFFECTS OF AN ACUTE ENTERIC DISEASE CHALLENGE ON IGF-1 AND IGFBP-3 GENE EXPRESSION IN PORCINE SKELETAL MUSCLE B. J. Johnson, J. P. Kyser, J. D. Dunn, A. T. Wyln, S. S. Dritz 1, J.
More informationThe potential future of targeted radionuclide therapy: implications for occupational exposure? P. Covens
The potentil future of trgeted rdionuclide therpy: implictions for occuptionl exposure? Introduction: Trgeted Rdionuclide Therpy (TRT) Systemic tretment Molecule lbelled with rdionuclide delivers toxic
More informationEffects of physical exercise on working memory and prefrontal cortex function in post-stroke patients
Effects of physicl exercise on working memory nd prefrontl cortex function in post-stroke ptients M Moriy, C Aoki, K Sktni Grdute School of Helth Sciences Reserch, Mjor of Physicl Therpy, TeikyoHeisei
More informationSponsor / Company: Sanofi Drug substance(s): AVE0005 (aflibercept)
These results re supplied for informtionl purposes only. Prescribing decisions should be mde bsed on the pproved pckge insert in the country of prescription. Sponsor / Compny: Snofi Drug substnce(s): AVE0005
More informationAOAC Official Method Determination of Isoflavones in Soy and Selected Foods Containing Soy
45.4.14 AOAC Officil Method 2001.10 Determintion of Isoflvones in Soy nd Selected Foods Contining Soy Extrction, Sponifiction, nd Liquid Chromtogrphy First Action 2001 (Applicble to the determintion of
More informationCord Injuries. on admission, and intermittent catheterization. (IC) was carried out until spontaneous voiding occurred.
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1982, P. 856-860 0095-1137/82/110856-05$02.00/0 Copyright 1982, Americn Society for Microbiology Vol. 16, No. 5 Pseudomons eruginos Coloniztion in Ptients with Spinl
More informationTHE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS
THE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS THE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS John F. Ptience nd Doug Gillis SUMMARY
More informationSafety and Tolerability of Subcutaneous Sarilumab and Intravenous Tocilizumab in Patients With RA
Sfety nd Tolerbility of Subcutneous Srilumb nd Intrvenous Tocilizumb in Ptients With RA Pul Emery, 1 Jun Rondon, 2 Anju Grg, 3 Hubert vn Hoogstrten, 3 Neil M.H. Grhm, 4 Ming Liu, 4 Nncy Liu, 3 Jnie Prrino,
More informationEfficacy of Pembrolizumab in Patients With Advanced Melanoma With Stable Brain Metastases at Baseline: A Pooled Retrospective Analysis
Efficcy of Pembrolizumb in Ptients With Advnced Melnom With Stble Brin Metstses t Bseline: A Pooled Retrospective Anlysis Abstrct 1248PD Hmid O, Ribs A, Dud A, Butler MO, Crlino MS, Hwu WJ, Long GV, Ancell
More informationUsing Paclobutrazol to Suppress Inflorescence Height of Potted Phalaenopsis Orchids
Using Pcloutrzol to Suppress Inflorescence Height of Potted Phlenopsis Orchids A REPORT SUBMITTED TO FINE AMERICAS Linsey Newton nd Erik Runkle Deprtment of Horticulture Spring 28 Using Pcloutrzol to Suppress
More informationC reactive protein: an aid to assessment and
C rective protein: n id to ssessment nd monitoring of cute pncretitis J Clin Pthol 1984;37:27-211 AD MAYR,* MJ McMAHON,* MARGART BOWN,t H COOPRt From the *University Deprtment ofsurgery, Generl Infrmry,
More informationGlucose is the most commonly used osmotic agent in
Peritonel Dilysis Interntionl, Vol. 32, pp. 545 551 doi: 10.3747/pdi.2011.00048 0896-8608/12 $3.00 +.00 Copyright 2012 Interntionl Society for Peritonel Dilysis ULTRAFILTRATION AND DIALYSIS ADEQUACY WITH
More informationResults of improvement in adequacy of intermittent hemodialysis in uremic patients
314 Grzegorzewsk AE, et l. Roczniki Akdemii Medycznej w Biłymstoku Vol. 50, 2005 Annles Acdemie Medice Bilostocensis Results of improvement in dequcy of intermittent hemodilysis in uremic ptients Grzegorzewsk
More informationENERGY CONTENT OF BARLEY
ENERGY CONTENT OF BARLEY VARIATION IN THE DIETARY ENERGY CONTENT OF BARLEY Shwn Firbirn, John Ptience, Hnk Clssen nd Ruurd Zijlstr SUMMARY Formultion of commercil pig diets requires n incresing degree
More informationRecommended Dosage Regimen for AVYCAZ (ceftazidime and avibactam) b. AVYCAZ 1.25 grams (ceftazidime 1 gram and avibactam 0.25 grams) every 8 hours
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include ll the informtion needed to use AVYCAZ sfely nd effectively. See full prescribing informtion for AVYCAZ. AVYCAZ (ceftzidime nd vibctm)
More informationOriginal Article. T Akter 1, N Islam 2, MA Hoque 3, S Khanam 4, HA khan 5, BK Saha 6. Abstract:
Fridpur Med. Coll. J. 214;9(2):61-67 Originl Article Nebuliztion by Isotonic Mgnesium Sulphte Solution with Provide Erly nd Better Response s Compred to Conventionl Approch ( Plus Norml Sline) in Acute
More informationDialysis Effluent. lines and catheters, and wound sites. An attempt was made. to discern those factors which might adversely affect the
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 1987, p. 2367-2371 0095-1137/87/122367-05$02.00/0 Copyright C 1987, Americn Society for Microbiology Vol. 25, No. 12 Lbortory Indices of Clinicl Peritonitis: Totl
More informationEffect of Sodium Polyanethol Sulfonate in Blood Cultures
JOURNAL OF CLINICAL MICROBIOLoGY, Feb. 1975, p. 119-123 Copyright 0 1975 Americn Society for Microbiology Vol. 1, No. 2 Printed in U.S.A. Effect of Sodium Polynethol Sulfonte in Blood Cultures JAN ENG
More informationcapacity in infants and children
Archives of Disese in Childhood, 1974, 49, 654. DDAVP test for estimtion of renl concentrting cpcity in infnts nd children A. S. ARONSON nd N. W. SVENNINGSEN From the Deprtment of Peditrics, University
More informationCheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer
CheckMte 53: Rndomized Results of Continuous vs -Yer Fixed-Durtion Nivolumb in Ptients With Advnced Non-Smll Cell Lung Cncer Abstrct 297O Spigel DR, McCleod M, Hussein MA, Wterhouse DM, Einhorn L, Horn
More informationPharmacokinetic Characterization of the Novel Pulmonary Delivery Excipient Fumaryl Diketopiperazine
Journl of Dibetes Science nd Technology Volume 4, Issue 5, September 2010 Dibetes Technology Society ORIGINAL ARTICLES Phrmcokinetic Chrcteriztion of the Novel Pulmonry Delivery Excipient Fumryl Diketopiperzine
More informationPNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 :
PNEUMOVAX 23 is recommended y the CDC for ll your pproprite dult ptients t incresed risk for pneumococcl disese 1,2 : Adults ged
More informationSupplementary Online Content
Supplementry Online Content Zulmn DM, Pl Chee C, Ezeji-Okoye SC, et l. Effect of n intensive outptient progrm to ugment primry cre for high-need Veterns Affirs ptients: rndomized clinicl tril. JAMA Intern
More informationExtraction and Some Functional Properties of Protein Extract from Rice Bran
Ksetsrt J. (Nt. Sci.) 40 : 209-214 (2006) Extrction nd Some Functionl Properties of Protein Extrct from Rice Brn Chockchi Theerkulkit*, Siree Chiseri nd Siriwt Mongkolknchnsiri ABSTRACT Rice brn protein
More informationGeographical influence on digit ratio (2D:4D): a case study of Andoni and Ikwerre ethnic groups in Niger delta, Nigeria.
Journl of Applied Biosciences 27: 1736-1741 ISSN 1997 5902 Geogrphicl influence on digit rtio (2D:4D): cse study of Andoni nd Ikwerre ethnic groups in Niger delt, Nigeri. Gwunirem, Isrel U 1 nd Ihemelndu,
More informationHematology TOONYA TURNER. IDEXX Services: Senior Profile with Heartworm -Standard CBC. RBC M/µL. Hematocrit
TOONYA TURNER PET OWNER: TURNER SPECIES: Cnine BREED: GENDER: Femle AGE: 1 Yers PATIENT ID: 17047 Fmily Pet Helth Cre 3623 Indin Hills Rod Dectur, Albm 35603 256-341-0200 ACCOUNT #: 87040 ATTENDING VET:
More informationSalmonella typhi from Blood
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 1978, p. 122-126 0095-1137/78/0007-0122$02.00/0 Copyright 1978 Americn Society for Microbiology Lbortory nd Clinicl Investigtion of Recovery of Slmonell typhi from
More informationGlobal Intellectual Deficits in Cystinosis
Americn Journl of Medicl Genetics 49:83-87 (1994) Globl Intellectul Deficits in Cystinosis Brbr L.H. Willims, Jerry A. Schneider, nd Doris A. Truner Deprtments of Neurosciences (B.L.H.W.. D.A.T.) nd Peditrics
More informationBeetroot juice and exercise: pharmacodynamic and dose-response relationships
J Appl Physiol 115: 325 336, 2013. First published My 2, 2013; doi:10.1152/jpplphysiol.00372.2013. Beetroot juice nd exercise: phrmcodynmic nd dose-response reltionships Lee J. Wylie, 1 Jmes Kelly, 1 Stephen
More informationUrinary Tract Infection in Women
C H A P T E R 1 8 Urinry Trct Infection in Women Toms L. Griebling, MD Associte Professor & Vice Chir of Urology University of Knss Knss City, Knss Contents INTRODUCTION........................................589
More informationImpact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting
Impct of Phrmcist Intervention on Dibetes Ptients in n Ambultory Setting Julie Stding, PhrmD, CDE, Jmie Herrmnn, PhrmD, Ryn Wlters, MS, Chris Destche, PhrmD, nd Aln Chock, PhrmD Dibetes is the seventh-leding
More informationShort-term therapy with lasting relief 2
# 1 PRESCRIBED MEDICATION APPROVED FOR IBS-D 1 * Short-term therpy with lsting relief 2 provided up to 6 months of symptom relief with 2-week tretment 2 Rnge of 6 to 24 weeks; medin of 10 weeks. Convenient
More information58 % 50 % REDUCTION IN RISK OF OVERT HE RECURRENCE 1
FOR ADULT PATIENTS WITH OVERT HEPATIC ENCEPHALOPATHY (HE) significntly reduced the risk of overt HE recurrence nd HE-relted hospitliztions 1 58 % 50 % REDUCTION IN RISK OF OVERT HE RECURRENCE 1 REDUCTION
More informationUrinary Tract Infection in Men
C H A P T E R 1 9 Urinry Trct Infection in Men Toms L. Griebling, MD Associte Professor & Vice Chir of Urology University of Knss Knss City, Knss Contents INTRODUCTION........................................623
More informationPROVEN ANTICOCCIDIAL IN NEW FORMULATION
PROVEN ANTICOCCIDIAL IN NEW FORMULATION Coxidin 100 microgrnulte A coccidiosttic dditive for roilers, chickens rered for lying nd turkeys Contins 100 g of monensin sodium per kg Aville s homogenous grnules
More informationAnemia in pediatric hemodialysis patients: Results from the 2001 ESRD Clinical Performance Measures Project
Kidney Interntionl, Vol. 64 (2003), pp. 1120 1124 Anemi in peditric hemodilysis ptients: Results from the 2001 ESRD Clinicl Performnce Mesures Project DIANE L. FRANKENFIELD, ALICA M. NEU, BRADLEY A. WARADY,
More informationVitamin D and Mushrooms: Enrichment With Pulsed UV Light. Michael Kalaras Department of Food Science The Pennsylvania State University
Vitmin D nd Mushrooms: Enrichment With Pulsed UV Light Michel Klrs Deprtment of Food Science The Pennsylvni Stte University Vitmin D Synthesis Source: http://vitmind.ucr.edu/imges/chem1.gif Vitmin D In
More informationmalabsorption in infants and children
rchives of Disese in Childhood, 1979, 54, 436-440 Breth hydrogen test for detecting lctose mlbsorption in infnts nd children Prevlence of lctose mlbsorption in Jpnese children nd dults OSMU NOS, YOSHIHIKO
More informationFeeding state and age dependent changes in melaninconcentrating hormone expression in the hypothalamus of broiler chickens
Supplementry Mterils Epub: No 2017_23 Vol. 65, 2018 https://doi.org/10.183/bp.2017_23 Regulr pper Feeding stte nd ge dependent chnges in melninconcentrting hormone expression in the hypothlmus of broiler
More informationBlood pressure and diurnal variation in sodium, potassium, and water excretion
Journl of Humn Hypertension (1998) 12, 363 371 1998 Stockton Press. All rights reserved 0950-9240/98 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE Blood pressure nd diurnl vrition in sodium,
More informationInvasive Pneumococcal Disease Quarterly Report July September 2018
Invsive Pneumococcl Disese Qurterly Report July Septemer Introduction Since 17 Octoer 2008, invsive pneumococcl disese (IPD) hs een notifile to the locl Medicl Officer of Helth under the Helth Act 1956.
More informationPredictors of Hospitalization in Male Marine Corps Recruits with Exertional Heat Illness
MILITARY MEDICINE, 169, 3:169, 2004 Predictors of Hospitliztion in Mle Mrine Corps Recruits with Exertionl Het Illness Gurntor: COL John W. Grdner, MC FS USA Contributors: Shilp Hkre, DrPH; COL John W.
More informationXII. HIV/AIDS. Knowledge about HIV Transmission and Misconceptions about HIV
XII. HIV/AIDS Knowledge bout HIV Trnsmission nd Misconceptions bout HIV One of the most importnt prerequisites for reducing the rte of HIV infection is ccurte knowledge of how HIV is trnsmitted nd strtegies
More informationThe RUTHERFORD-2 trial in heterozygous FH: Results and implications
The RUTHERFORD-2 tril in heterozygous FH: Results nd implictions Slide deck kindly supplied s n eductionl resource by Professor Derick Rl MD PhD Crbohydrte & Lipid Metbolism Reserch Unit University of
More informationCHAPTER- 3 ANALYSIS OF PATHOPHYSIOLOGICAL MARKER ENZYMES, LIPID AND PROTEIN PROFILES IN CONTROL AND EXPERIMENTAL ANIMALS
CHAPTER- 3 CHAPTER- 3 ANALYSIS OF PATHOPHYSIOLOGICAL MARKER ENZYMES, LIPID AND PROTEIN PROFILES IN CONTROL AND EXPERIMENTAL ANIMALS 3.1. INTRODUCTION The liver, hs vriety of trnsminse to synthesize nd
More informationInactivation of Myxoviruses by Calcium Elenolate
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1975, p. 194-199 Copyright i 1975 Americn Society for Microbiology Vol. 8, No. 2 Printed in U.S.A Inctivtion of Myxoviruses by Clcium Elenolte HAROLD E. RENIS
More informationAddendum to the Evidence Review Group Report on Aripiprazole for the treatment of schizophrenia in adolescents (aged years)
Addendum to the Evidence Review Group Report on Aripiprzole for the tretment of schizophreni in dolescents (ged 15-17 yers) Produced by Authors Correspondence to Southmpton Helth Technology Assessments
More informationSingle-Molecule Studies of Unlabelled Full-Length p53 Protein Binding to DNA
Single-Molecule Studies of Unlbelled Full-Length p53 Protein Binding to DNA Philipp Nuttll, 1 Kidn Lee, 2 Pietro Ciccrell, 3 Mrco Crminti, 3 Giorgio Ferrri, 3 Ki- Bum Kim, 2 Tim Albrecht 1* 1 Imperil College
More informationEmerging Options for Thromboprophylaxis After Orthopedic Surgery: A Review of Clinical Data
Emerging Options for Thromboprophylxis After Orthopedic Surgery: A Review of Clinicl Dt Bob L. Lobo, Phrm.D. In four rndomized, controlled studies of ptients undergoing orthopedic surgery, the ntithrombotic
More informationOpioid Use and Survival at the End of Life: A Survey of a Hospice Population
532 Journl of Pin nd Symptom Mngement Vol. 32 No. 6 December 2006 NHPCO Originl Article Opioid Use nd Survivl t the End of Life: A Survey of Hospice Popultion Russell K. Portenoy, MD, Un Sibircev, BA,
More informationUSE OF SORGHUM-BASED DISTILLERS GRAINS IN DIETS FOR NURSERY AND FINISHING PIGS
Swine Dy 1996 USE OF SORGHUM-BASED DISTILLERS GRAINS IN DIETS FOR NURSERY AND FINISHING PIGS B. W. Senne, J. D. Hncock, I. Mvromichlis, S. L. Johnston, P. S. Sorrell, I. H. Kim, nd R. H. Hines Summry Two
More informationInfections with Cephapirin
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 1974, p. 274-281 Copyright @ 1974 Americn Society for Microbiology Vol. 6, No. 3 Printed in U.S.A. Tretment of Pneumoni nd Other Serious Bcteril Infections
More informationSYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT
Finl Arevited Clinicl Study Report Nme of Sponsor/Compny: Bristol-Myers Squi Ipilimum Individul Study Tle Referring to the Dossier (For Ntionl Authority Use Only) Nme of Finished Product: Yervoy Nme of
More informationCLPNA Pressure Ulcers ecourse: Module 5.3 Quiz I page 1
CLPNA Pressure Ulcers ecourse: Module 5.3 Quiz I 1. Clensing is the process of clening nd sterilizing pressure ulcer wound. 2. How often should pressure ulcer wound nd surrounding skin be clensed?. Every
More informationInvasive Pneumococcal Disease Quarterly Report. July September 2017
Invsive Pneumococcl Disese Qurterly Report July September 2017 Prepred s prt of Ministry of Helth contrct for scientific services by Rebekh Roos Helen Heffernn October 2017 Acknowledgements This report
More information(Received for publication February 17, 1944) Since, as has been demonstrated by Enders (3),
CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XII. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PREVENTION
More informationM Sandström 1, MO Karlsson 1, P Ljungman 2, Z Hassan 3, EN Jonsson 1, C Nilsson 3, O Ringden 4, GÖberg 5, A Bekassy 6 and M Hassan 3.
(21) 28, 657 664 21 Nture Publishing Group All rights reserved 268 3369/1 $15. www.nture.com/bmt Phrmcokinetics Popultion phrmcokinetic nlysis resulting in tool for dose individuliztion of busulphn in
More informationLipase and Pancreatic Amylase Activities in Tissues and in Patients with Hyperamylasemia
CLINICAL CHEMISTRY Originl Article Lipse nd Pncretic Amylse Activities in Tissues nd in Ptients with Hypermylsemi FRED APPLE, PH.D, PETER BENSON, M.D., LYNNE PREESE, MT, M.B.A., STEVEN EASTEP, M.D., LAURA
More informationInput from external experts and manufacturer on the 2 nd draft project plan Stool DNA testing for early detection of colorectal cancer
Input externl experts nd mnufcturer on the 2 nd drft project pln Stool DNA testing for erly detection of colorectl cncer (Project ID:OTJA10) All s nd uthor s replies on the 2nd drft project pln Stool DNA
More informationAnalysis of alternatives for insulinizing patients to achieve glycemic control and avoid accompanying risks of hypoglycemia
284 Anlysis of lterntives for izing ptients to chieve glycemic control nd void ccompnying risks of hypoglycemi JIALIN GAO 1,2*, QIANYIN XIONG 1,2*, JUN MIAO 1*, YAO ZHANG 2,3, LIBING XIA 1, MEIQIN LU 1,
More informationXALKORI (crizotinib) Is Available Through Specialty Pharmacies
XALKORI (crizotinib) Is Avilble Through Specilty Phrmcies Specilty Phrmcy Ordering Process The Provider s Office Submits XALKORI prescriptions to the specilty phrmcy vi: Phone Fx Internet Submits ny supporting
More information27 June Bmnly L. WALTER ET AL.: RESPONSE OF CERVICAL CANCERS TO IRRADIATION
27 June 1964 Bmnly MEDICAL JOURNAL L. WALTER ET AL.: RESPONSE OF CERVICAL CANCERS TO IRRADIATION x 1,638.) FIG. 2.-Foci of sme tumour s in Fig. 1 contining vible tumour cells with scnty cytoplsm, reltively
More informationAssessment of Depression in Multiple Sclerosis. Validity of Including Somatic Items on the Beck Depression Inventory II
Assessment of Depression in Multiple Sclerosis Vlidity of Including Somtic Items on the Beck Depression Inventory II Peggy Crwford, PhD; Noh J. Webster, MA Signs nd symptoms of multiple sclerosis (MS)
More informationAnalysis of Regulatory of Interrelated Activity of Hepatocyte and Hepatitis B Viruses
Interntionl Journl of Biomedicl Mterils Reserch 8 6(): -7 http://www.sciencepublishinggroup.com/j/ijbmr doi:.648/j.ijbmr.86. ISSN: 33-756 (Print) ISSN: 33-7579 (Online) Anlysis of Regultory of Interrelted
More informationEvaluation of New Urinary Tract Infection Screening Devices
APPLIED MICROBIOLOGY, Aug. 1973, p. 196-201 Copyright 0 1973 Americn Society for Microbiology Vol. 26, No. 2 Printed in U.S.A. Evlution of New Urinry Trct Infection Screening Devices WILLIAM A. CRAIG,
More informationStart ORKAMBI today. INDICATIONS AND USAGE IMPORTANT SAFETY INFORMATION. Sydney Age 4
F O R H E A L T H C A R E P R O F E S S I O N A L S For ptients ge 2 yers nd older who re homozygous for the F508del muttion 1,2 Modify the course. Strt tody. Sydney Age 4 F508del/F508del INDICATIONS AND
More informationSandra Grbić Vladimir Lukić Ivan Kovačević Jelena Parojčić Zorica Đurić
Deprtment of Phrmceuticl Technology nd Cosmetology Fculty of Phrmcy University of Belgrde An investigtion into the possibilities nd limittions of in silico bsorption modeling: GstroPlus TM simultion of
More informationSimulating the Effect of Exercise on Urea Clearance in
BRIEF COMMUNICATION Simulting the Effect of Exercise on Ure Clernce in Hemodily si s STEPHEN W. SMYE,* ELIZABETH J. LINDLEY,* nd ERIC J. WILLt Deprtments of *Medicl Physics nd Renl Medicine, St. Jmes s
More informationThe Effects of Small Sized Rice Bowl on Carbohydrate Intake and Dietary Patterns in Women with Type 2 Diabetes
Originl Article doi: 10.4093/kdj.2010.34.3.166 pissn 1976-9180 eissn 2093-2650 The Effects of Smll Sized Rice Bowl on Crbohydrte Intke nd Dietry Ptterns in Women with Type 2 Dibetes Hee-Jung Ahn 1, *,
More informationRelationship between food availability, glycerol and glycogen levels in lowtemperature challenged rainbow smelt Osmerus mordax
866 The Journl of Experimentl Biology, 866-87 Published by The Compny of Biologists 7 doi:.4/jeb.749 Reltionship between food vilbility, glycerol nd glycogen levels in lowtemperture chllenged rinbow smelt
More informationin the above manner contained 105 to 106 plaqueforming virus preparation was used without further manipulation
INFECTION AND IMMUNITY, June 1978, p. 660-664 0019-9567/78/0020-tE60$02.00/0 Copyright 1978 Americn Society for Microbiology Vol. 20, No. 3 Printed in U.S.A. Enzyme-Linked Immunosorbent Assy for Mesurement
More informationCommunity. Profile Yellowstone County. Public Health and Safety Division
Community Helth Profile 2015 Yellowstone County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationThe accuracy of creatinine clearance with and without
Postgrd Med J (1991) 67, 42-46 ) The Fellowship of Postgrdute Medicine, 1991 The ccurcy of cretinine clernce with nd without urine collection s mesure of glomerulr filtrtion rte D.G. Wller,' J.S. Fleming,2
More informationCommunity. Profile Big Horn County. Public Health and Safety Division
Community Helth Profile 2015 Big Horn County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Lewis & Clark County. Public Health and Safety Division
Community Helth Profile 2015 Lewis & Clrk County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Missoula County. Public Health and Safety Division
Community Helth Profile 2015 Missoul County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationCheck your understanding 3
1 Wht is the difference etween pssive trnsport nd ctive trnsport? Pssive trnsport is the movement of prticles not requiring energy. Movement of prticles in ctive trnsport uses energy. 2 A gs tp in the
More informationGranulocytopenic Cancer Patients
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUIY 1986, P. 64-68 0066-4804/86/070064-05$02.00/0 Copyright 1986, Americn Society for Microbiology Vol. 30, No. 1 Rndomized Comprison between Two Ceftzidime-Contining
More informationPreservative Resistance in Yeast Species
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, Nov. 1989, p. 2995-2999 Vol. 55, No. 11 99-224/89/112995-5$2./ Copyright 1989, Americn Society for Microbiology Reltionships mong Cell Size, Membrne Permebility,
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Pge The hndle http://hdl.hndle.net/1887/5818 holds vrious files of this Leiden University disserttion Author: Olofsen, E. Title: Phrmcokinetic nd phrmcodynmic nlysis in nesthesi : modeling odyssey
More informationEffect of Preoperative Intravenous Methocarbamol and Intravenous Acetaminophen on Opioid Use After Primary Total Hip and Knee Replacement
Feture Article Effect of Preopertive Intrvenous Methocrbmol nd Intrvenous Acetminophen on Opioid Use After Primry Totl Hip nd Knee Replcement THOMAS D. LOOKE, MD, PHD; CAMERON T. KLUTH, MBA bstrct Between
More informationIBUPROFEN DISPOSITION IN OBESE INDIVIDUALS
1117 BUPROFEN DSPOSTON N OBESE NDVDUALS DARRELL R. ABERNETHY nd DAVD J. GREENBLATT Eleven obese subjects (weight 114? 11 kg, men f SE) nd 11 ge-mtched subjects with norml body weight (61 f 3 kg) were given
More informationT.S. Kurki a, *,U.Häkkinen b, J. Lauharanta c,j.rämö d, M. Leijala c
Europen Journl of Crdio-thorcic Surgery 20 (2001) 1183 1187 www.elsevier.com/locte/ejcts Evlution of the reltionship between preopertive risk scores, postopertive nd totl length of stys nd hospitl costs
More informationMETHOD 4010 SCREENING FOR PENTACHLOROPHENOL BY IMMUNOASSAY
METHOD 4010 SCREENING FOR PENTACHLOROPHENOL BY IMMUNOASSAY 1.0 SCOPE AND APPLICATION 1.1 Method 4010 is procedure for screening solids such s soils, sludges, nd queous medi such s wste wter nd lechtes
More informationWSU Tree Fruit Research and Extension Center, Wenatchee (509) ext. 265;
FINAL REPORT WTFRC Project # AH-1-5 WSU Project # 13C-355-3 Project title: PI: Orgniztion: Coopertors: of Sunburn in Apples with RAYNOX Lrry Schrder, Horticulturist WSU Tree Fruit Reserch nd Extension
More informationEffect of environmental stress on biochemical and physiological features in cultured fish
Effect of environmentl stress on biochemicl nd physiologicl fetures in cultured fish Toshiki Nkno, Toshiysu Ymguchi, nd Yoshihiro Ochii Grd. Sch. Agric. Sci., Tohoku Univ., Sendi, Jpn Fmous Smuri Mr. Msmune
More informationEffects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes Mellitus
Originl Article Others Dibetes Metb J 215;39:335-341 http://dx.doi.org/1.493/dmj.215.39.4.335 pissn 2233-679 eissn 2233-687 DIABETES & METABOLISM JOURNAL Effects of 6-Month Sitgliptin Tretment on Insulin
More informationEstimating the impact of the 2009 influenza A(H1N1) pandemic on mortality in the elderly in Navarre, Spain
Rpid communictions Estimting the impct of the influenz pndemic on mortlity in the elderly in Nvrre, Spin J Cstill (jcstilc@nvrr.es) 1, J Etxeberri 1, E Ardnz 1, Y Floristán 1, R López Escudero 1, M Guevr
More information